Dirk O. Stichtenoth

1.2k total citations
31 papers, 900 citations indexed

About

Dirk O. Stichtenoth is a scholar working on Pharmacology, Biochemistry and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Dirk O. Stichtenoth has authored 31 papers receiving a total of 900 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pharmacology, 9 papers in Biochemistry and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Dirk O. Stichtenoth's work include Inflammatory mediators and NSAID effects (14 papers), Eicosanoids and Hypertension Pharmacology (7 papers) and Nitric Oxide and Endothelin Effects (4 papers). Dirk O. Stichtenoth is often cited by papers focused on Inflammatory mediators and NSAID effects (14 papers), Eicosanoids and Hypertension Pharmacology (7 papers) and Nitric Oxide and Endothelin Effects (4 papers). Dirk O. Stichtenoth collaborates with scholars based in Germany, United States and Switzerland. Dirk O. Stichtenoth's co-authors include Dimitrios Tsikas, Jürgen C. Frölich, Frank‐Mathias Gutzki, Marc Peters‐Golden, Leslie J. Crofford, Huimin Bian, Per‐Johan Jakobsson, Staffan Thorén, Maria-Theresia Suchy and Brunhilde Wagner and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Analytical Chemistry.

In The Last Decade

Dirk O. Stichtenoth

29 papers receiving 860 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dirk O. Stichtenoth Germany 14 440 199 166 138 119 31 900
Akiyoshi Hara Japan 16 371 0.8× 405 2.0× 260 1.6× 276 2.0× 66 0.6× 50 1.4k
A. Buntinx Belgium 14 357 0.8× 234 1.2× 81 0.5× 207 1.5× 39 0.3× 23 1.0k
Maria R. Panara Italy 15 838 1.9× 180 0.9× 278 1.7× 111 0.8× 191 1.6× 34 1.3k
N A Payne United States 17 318 0.7× 264 1.3× 149 0.9× 197 1.4× 38 0.3× 32 1.2k
Karen A. Munger United States 19 183 0.4× 364 1.8× 210 1.3× 308 2.2× 61 0.5× 41 1.2k
Nádia Maria Martins Brazil 16 169 0.4× 398 2.0× 56 0.3× 72 0.5× 46 0.4× 18 1.5k
Asko Riutta Finland 19 114 0.3× 166 0.8× 86 0.5× 189 1.4× 53 0.4× 52 884
Erkki Seppälä Finland 16 250 0.6× 107 0.5× 92 0.6× 273 2.0× 48 0.4× 60 872
Serena Viappiani Italy 14 119 0.3× 304 1.5× 69 0.4× 215 1.6× 164 1.4× 21 1.3k
Yosuke Kishimoto Japan 21 129 0.3× 323 1.6× 85 0.5× 205 1.5× 80 0.7× 41 1.1k

Countries citing papers authored by Dirk O. Stichtenoth

Since Specialization
Citations

This map shows the geographic impact of Dirk O. Stichtenoth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk O. Stichtenoth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk O. Stichtenoth more than expected).

Fields of papers citing papers by Dirk O. Stichtenoth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk O. Stichtenoth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk O. Stichtenoth. The network helps show where Dirk O. Stichtenoth may publish in the future.

Co-authorship network of co-authors of Dirk O. Stichtenoth

This figure shows the co-authorship network connecting the top 25 collaborators of Dirk O. Stichtenoth. A scholar is included among the top collaborators of Dirk O. Stichtenoth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dirk O. Stichtenoth. Dirk O. Stichtenoth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Framme, Carsten, Nicolas Feltgen, Ricarda G. Schumann, Dirk O. Stichtenoth, & Lars‐Olof Hattenbach. (2022). Regression einer idiopathischen epiretinalen Gliose – Kasuistik und Überlegungen zum Mechanismus. Die Ophthalmologie. 119(8). 801–806. 2 indexed citations
2.
3.
4.
Bolten, W., et al.. (2016). DGRh-Empfehlungen zur Implementierung aktueller Sicherheitsaspekte in die NSAR-Therapie muskuloskelettaler Schmerzen. Zeitschrift für Rheumatologie. 75(1). 103–116. 11 indexed citations
5.
Fischbach, Wolfgang, Christoph Baerwald, Harald Darius, et al.. (2013). Schmerztherapie mit traditionellen NSAR und Coxiben – eine interdisziplinäre Betrachtung. DMW - Deutsche Medizinische Wochenschrift. 138(3). 91–96. 4 indexed citations
6.
Zoerner, Alexander A., Christoph Schroeder, Arslan Arinc Kayacelebi, et al.. (2013). A validated, rapid UPLC–MS/MS method for simultaneous ivabradine, reboxetine, and metoprolol analysis in human plasma and its application to clinical trial samples. Journal of Chromatography B. 927. 105–111. 24 indexed citations
7.
Tsikas, Dimitrios, Maria-Theresia Suchy, Paschalis Tossios, et al.. (2012). Glutathione promotes prostaglandin H synthase (cyclooxygenase)‐dependent formation of malondialdehyde and 15(S)‐8‐iso‐prostaglandin F2α. FEBS Letters. 586(20). 3723–3730. 50 indexed citations
8.
Zoerner, Alexander A., Dirk O. Stichtenoth, Stefan Engeli, et al.. (2011). Allergen Challenge Increases Anandamide in Bronchoalveolar Fluid of Patients With Allergic Asthma. Clinical Pharmacology & Therapeutics. 90(3). 388–391. 25 indexed citations
9.
Voigt, Cornelia, Cornelius K. Donat, W Härtig, et al.. (2011). Effect of leukotriene inhibitors on evolution of experimental brain contusions. Neuropathology and Applied Neurobiology. 38(4). 354–366. 10 indexed citations
10.
Hunt, Richard H., Ángel Lanas, Dirk O. Stichtenoth, & Carmelo Scarpignato. (2009). Myths and facts in the use of anti-inflammatory drugs. Annals of Medicine. 41(6). 423–437. 31 indexed citations
11.
Becker, Jan U., et al.. (2007). Acute kidney injury due to deferoxamine in a renal transplant patient. Nephrology Dialysis Transplantation. 23(3). 1061–1064. 11 indexed citations
12.
Stichtenoth, Dirk O., et al.. (2005). Effects of specific COX-2-inhibition on renin release and renal and systemic prostanoid synthesis in healthy volunteers. Kidney International. 68(5). 2197–2207. 50 indexed citations
13.
Stichtenoth, Dirk O., et al.. (2005). Verbrauch von Medikamenten nach Verfallsfrist?. DMW - Deutsche Medizinische Wochenschrift. 130(45). 2596–2597. 2 indexed citations
14.
Stichtenoth, Dirk O.. (2004). The Second Generation of COX-2 Inhibitors: Clinical Pharmacological Point of View. Mini-Reviews in Medicinal Chemistry. 4(6). 617–624. 11 indexed citations
15.
Stichtenoth, Dirk O., et al.. (2004). Effects of carvedilol on oxidative stress in human endothelial cells and healthy volunteers. European Journal of Clinical Pharmacology. 60(2). 83–88. 25 indexed citations
16.
Stichtenoth, Dirk O., et al.. (2003). The Second Generation of COX-2 Inhibitors. Drugs. 63(1). 33–45. 121 indexed citations
17.
Stichtenoth, Dirk O., Staffan Thorén, Huimin Bian, et al.. (2001). Microsomal Prostaglandin E Synthase Is Regulated by Proinflammatory Cytokines and Glucocorticoids in Primary Rheumatoid Synovial Cells. The Journal of Immunology. 167(1). 469–474. 238 indexed citations
18.
Stichtenoth, Dirk O. & Jürgen C. Frölich. (2000). COX-2 and the Kidneys. Current Pharmaceutical Design. 6(17). 1737–1753. 48 indexed citations
19.
Stichtenoth, Dirk O., Brunhilde Wagner, & Jürgen C. Frölich. (1997). Effects of Meloxicam and Indomethacin on Cyclooxygenase Pathways in Healthy Volunteers. Journal of Investigative Medicine. 45(2). 44–49. 40 indexed citations
20.
Tsikas, Dimitrios, et al.. (1993). Enzymatic and chemical labelling of prostaglandin E1 and 13,14‐dihydro‐15‐keto‐prostaglandin E1. Journal of Labelled Compounds and Radiopharmaceuticals. 33(12). 1139–1149. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Akiyoshi Hara Breakdown of academic impact, for papers by A. Buntinx Breakdown of academic impact, for papers by Maria R. Panara Breakdown of academic impact, for papers by N A Payne Breakdown of academic impact, for papers by Karen A. Munger Breakdown of academic impact, for papers by Nádia Maria Martins Breakdown of academic impact, for papers by Asko Riutta Breakdown of academic impact, for papers by Erkki Seppälä Breakdown of academic impact, for papers by Serena Viappiani Breakdown of academic impact, for papers by Yosuke Kishimoto
Rankless by CCL
2026